Ferrán Rius
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Thyroid Disorders and Treatments
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Thyroid Disorders and Treatments 6
- Diabetes Treatment and Management 4
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
-
- Advanced Glycation End Products research 5
- Co-authors
- Marta Hernández (16 shared papers)Anna Sanmartı́ (5 shared papers)Isabel Salinas (6 shared papers)Albert Lecube (14 shared papers)Dı́dac Mauricio (10 shared papers)Jordi L. Reverter (3 shared papers)Anna Lucas (2 shared papers)Enric Sánchez (11 shared papers)
In The Last Decade
Ferrán Rius
42 papers receiving 3.3k citations
Ferrán Rius's Hit Papers
Peers
Comparison fields: 5 of 94
- Endocrinology, Diabetes and Metabolism 2.3k
- Nephrology 445
- Cardiology and Cardiovascular Medicine 298
- Clinical Biochemistry 35
- Transplantation 21
Countries citing papers authored by Ferrán Rius
This map shows the geographic impact of Ferrán Rius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferrán Rius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferrán Rius more than expected).
Fields of papers citing papers by Ferrán Rius
This network shows the impact of papers produced by Ferrán Rius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferrán Rius. The network helps show where Ferrán Rius may publish in the future.
Co-authors
The 25 scholars most cited alongside Ferrán Rius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2345 |
| 2 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 498 |
| 3 | 1999 | 70 | |
| 4 | 1997 | 60 | |
| 5 | 2013 | 51 | |
| 6 | 1997 | 45 | |
| 7 | 2014 | 34 | |
| 8 | 2019 | 27 | |
| 9 | 2018 | 23 | |
| 10 | 1995 | 19 | |
| 11 | 2003 | 19 | |
| 12 | 2017 | 18 | |
| 13 | 2019 | 18 | |
| 14 | 2019 | 15 | |
| 15 | 2019 | 14 | |
| 16 | 2020 | 14 | |
| 17 | 2019 | 13 | |
| 18 | 2020 | 13 | |
| 19 | 2018 | 12 | |
| 20 | 2020 | 12 |
About Ferrán Rius
Ferrán Rius is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Nephrology, Physiology and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 3.5k indexed citations. Recurring topics across this work include Thyroid Disorders and Treatments (6 papers), Advanced Glycation End Products research (5 papers), Chronic Kidney Disease and Diabetes (4 papers), Diabetes Treatment and Management (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Body Composition Measurement Techniques (3 papers), Cardiovascular Disease and Adiposity (2 papers) and Nutritional Studies and Diet (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Nephrology (445 citations), Cardiology and Cardiovascular Medicine (298 citations), Clinical Biochemistry (35 citations) and Transplantation (21 citations). Ferrán Rius has collaborated with scholars based in Spain, Tunisia and Italy. Frequent co-authors include Marta Hernández, Anna Sanmartı́, Isabel Salinas, Albert Lecube, Dı́dac Mauricio, Jordi L. Reverter, Anna Lucas, Enric Sánchez, Eduarda Pizarro and Carolina López‐Cano. Their work appears in journals such as PLoS ONE, Nutrients, The Lancet, Acta Diabetologica and Patient Preference and Adherence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.